The US Food and Drug Administration says it has issued an emergency use authorization for the first at-home Covid-19 test that uses saliva samples
Rutgers University's RUCDR Infinite Biologics lab received an amended emergency authorization late Thursday. With the test, people can collect their own saliva at home and send their saliva samples to a lab for results.Testing for Covid-19 so far has usually involved nose or throat swab samples.
A preservation agent will appear, blue in color, and once the whole sample is blue, it's put back in a biohazard bag provided with the kit and sent to a lab for testing."Authorizing additional diagnostic tests with the option of at-home sample collection will continue to increase patient access to testing for COVID-19.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA Authorizes First-Ever Crispr Application For COVID-19 Coronavirus TestThe FDA granted its first-ever emergency use authorization for the gene-editing technology Crispr—greenlighting a coronavirus diagnostic test developed by Cambridge, Massachusetts-based Sherlock Biosciences
Lire la suite »
Macy's delays first-quarter results to July 1, citing COVID-19 disruptionDepartment store chain Macy's Inc on Thursday delayed its first-quarter earnings report to July 1, citing significant business disruption due to the COVID-19 pandemic, which has also led to delay in financial statement preparation.
Lire la suite »
First Death Of Detainee In An ICE Detention Center From COVID-19Carlos Escobar-Mejia, 57, had been in ICE custody since Jan. 10, when he was stopped in a car by the Border Patrol in Chula Vista, Calif. Before then, he had been living in the U.S. for 40 years.
Lire la suite »
First child death from mysterious COVID-19-related illness is reported in the U.SA 5-year-old boy in New York becomes the first child in the US to die from a rare syndrome believed to be linked to COVID-19.
Lire la suite »